Restless Legs Syndrome

Restless legs syndrome is characterized by an unpleasant sensation in the legs and sometimes arms accompanied by a strong urge to move the affected limbs. It typically occurs during periods of inactivity and is temporarily relieved by movement. Restless legs syndrome may be caused by iron deficiency or dopamine imbalances. Find the latest research on restless legs syndrome here.

October 10, 2020
Review
Open Access

Pregabalin-associated movement disorders: A literature review

Brain Circulation
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
September 24, 2020
Open Access

Cannabis Use for Restless Legs Syndrome and Uremic Pruritus in in patients treated with maintenance dialysis: A Survey

Canadian Journal of Kidney Health and Disease
Daniel SamahaDeborah Zimmerman
October 9, 2020

Functional connectivity and topology in patients with restless legs syndrome: A case-control resting-state functional MRI study

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Noora TuovinenChristoph Scherfler
October 9, 2020

Evaluation of sleep quality and restless legs syndrome in adult patients with sickle cell anemia

Sleep & Breathing = Schlaf & Atmung
Nazan Şimşek ErdemErdal Kurtoğlu
October 2, 2020
Review
Open Access

Dialysis Patients With Restless Leg Syndrome: Can We Relieve Their Suffering?

Curēus
Marina SalibIvan Cancarevic
October 22, 2020
Review
Open Access

Unraveling the Mysteries of Restless Leg Syndrome

Curēus
Mohammad D MemonIvan Cancarevic
September 20, 2020

Consensus diagnostic criteria for a newly defined pediatric sleep disorder: restless sleep disorder (RSD)

Sleep Medicine
Lourdes M DelRossoInternational Restless Legs Syndrome Study Group (IRLSSG)
October 9, 2020
Review

Sleep Issues in Parkinson's Disease and Their Management

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
José Rafael P Zuzuárregui, Emmanuel H During
September 23, 2020

Standard procedures for the diagnostic pathway of sleep-related epilepsies and comorbid sleep disorders: an EAN, ESRS and ILAE-Europe consensus review

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Lino NobiliLuca Vignatelli
October 21, 2020

Sleep and wake disorders in epilepsy

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
A B KozhokaruA S Orlova
September 22, 2020
Open Access

COVID-19-associated sleep disorders: A case report

Neurobiology of Sleep and Circadian Rhythms
Abeer A TonyAmal A Mahmoud
October 5, 2020

Delusional parasitosis. A multicenter retrospective study in Spanish infectious disease services

Enfermedades infecciosas y microbiología clínica
Beatriz Rodríguez-AlonsoJosé-Luis Pérez-Arellano
October 3, 2020
Open Access

Clinical Features and Correlates of Poor Nighttime Sleepiness in Patients with Parkinson's Disease

Parkinson's Disease
Xiaoling QinDianshuai Gao
September 19, 2020
Review

Point-of-care echocardiography for the evaluation of right-to-left cardiopulmonary shunts: a narrative review

Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie
Tim MontriefJeffrey Scott

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share a considerable proportion of characteristics including the same neuropathological substrate of abnormally phosphorylated TAR DNA binding protein (TDP-43). Here are the latest discoveries pertaining to ALS, FTD and TDP-43.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Alpha-Synuclein Structure and Function

α-Synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research on α-Synuclein structure and function.

Antisense Oligonucleotide Therapies - ND and ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/restless-legs-syndrome/35c9cbcf-d775-4500-bcf6-e0b242280118